Shamburg News · 8-K filed Nov 17, 2026, 4:30 PM EST
Evommune Approves Retention Awards and Option Repricing for Executive Officers
EVMN · Evommune, Inc.
- Leadership change
- Material agreement
- Other
- Materiality: medium
On November 13, 2026, the Compensation Committee of Evommune, Inc.'s Board approved amendments to employment agreements with executive officers, including CEO Luis Peña ($686,600), CFO Kyle Carver ($565,000), and Chief Business & Legal Officer Gregory Moss ($595,000), providing cash retention awards vesting in two installments subject to continued employment and, for the second installment, a $15.00 per share stock price condition. The Committee also repriced outstanding stock options with exercise prices of $16.00 or more to $7.63 per share, the November 13, 2026 closing price, subject to a 12-month retention period and a premium exercise price requirement. The repricing covers 3,692,840 shares underlying eligible options under the 2025 Equity Incentive Plan.
Source: SEC EDGAR, Form 8-K, Item 5.02, accession 0001193125-26-465600.
Written from the filing by Shamburg Markets. Figures are as reported by the company.